Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex vs Neostigmine in Pediatric Appendectomy
NCT05256901Phase 4Terminated
- Sponsor
- Emory University
- Start
- Jul 2023
- Primary completion
- Jul 2024
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Sugammadex in appendicitis, sponsored by Emory University. Started Jul 2023; status: terminated.
02
Drugs
Sugammadex
03
Conditions
appendicitis
Beyond the preview
Go deeper on NCT05256901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05256901.